Cite
HARVARD Citation
McNamara, L. et al. (2017). High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine. American journal of transplantation. 17 (9), pp. 2481-2484. [Online].